Aphea.Bio
Product development company creating next-generation biopesticides derived from natural microorganisms
1
Funding Rounds
$77.0m
Money raised
Overview
Product development company creating next-generation biopesticides derived from natural microorganisms
- Website:
- Business model: B2B
- Headquarters: Ghent
Funding series
Funding Series Analysis
The company Aphea.Bio has raised a total of $77m in funding over 1 rounds.
Key Insights:
- Aphea.Bio July 2023 Series C Funding Round: $77m
Aphea.Bio July 2023 Series C Funding Round
$77m
Industries
Aphea.Bio is active in the following industries: